Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure Acq. announced Appointed director Inv. presentation
|
Midatech Pharma US Inc. (DARA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/04/2015 |
8-K
| Acquisition/merger/asset purchase announced
Docs:
|
"Agreement and Plan of Merger, among DARA BioSciences, Inc., Midatech Pharma, PLC, Merlin Acquisition Sub, Inc., Duke Acquisition Sub, Inc. and Shareholder Representative Services, LLC",
"Form of Contingent Value Rights Agreement",
"Form of Voting Agreement",
"- DARA’s Commercial Organization Key Driver of Agreement - Combined Organization Provides Pipeline of Oncology Products for U.S. Commercialization" |
|
|
|